News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
748,777 Results
Type
Article (44238)
Company Profile (467)
Press Release (704057)
Multimedia
Podcasts (145)
Webinars (23)
Section
Business (209535)
Career Advice (2049)
Deals (36226)
Drug Delivery (140)
Drug Development (84153)
Employer Resources (174)
FDA (16811)
Job Trends (15231)
News (354709)
Policy (33306)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2689)
Accelerated approval (54)
Adcomms (31)
Allergies (179)
Alliances (51116)
ALS (223)
Alzheimer's disease (1869)
Antibody-drug conjugate (ADC) (503)
Approvals (17185)
Artificial intelligence (715)
Autoimmune disease (323)
Automation (57)
Bankruptcy (374)
Best Places to Work (11840)
BIOSECURE Act (20)
Biosimilars (228)
Biotechnology (325)
Bladder cancer (204)
Brain cancer (77)
Breast cancer (789)
Cancer (6138)
Cardiovascular disease (505)
Career advice (1743)
Career pathing (45)
CAR-T (349)
CDC (59)
Celiac Disease (3)
Cell therapy (962)
Cervical cancer (49)
Clinical research (72938)
Collaboration (2209)
Company closure (5)
Compensation (1441)
Complete response letters (91)
COVID-19 (2811)
CRISPR (118)
C-suite (1205)
Cystic fibrosis (163)
Data (8272)
Decentralized trials (3)
Denatured (46)
Depression (176)
Dermatology (93)
Diabetes (607)
Diagnostics (7026)
Digital health (57)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (352)
Drug pricing (213)
Drug shortages (32)
Duchenne muscular dystrophy (308)
Earnings (93469)
Editorial (70)
Employer branding (21)
Employer resources (153)
Events (123759)
Executive appointments (1130)
FDA (20661)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1827)
Gene editing (257)
Generative AI (58)
Gene therapy (791)
GLP-1 (1113)
Government (4841)
Grass and pollen (6)
Guidances (412)
Healthcare (19426)
HIV (84)
Huntington's disease (58)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (105)
Immunology and inflammation (324)
Immuno-oncology (105)
Indications (198)
Infectious disease (3168)
Inflammatory bowel disease (229)
Inflation Reduction Act (17)
Influenza (140)
Intellectual property (303)
Interviews (319)
IPO (16959)
IRA (53)
Job creations (3718)
Job search strategy (1443)
JPM (67)
Kidney cancer (19)
Labor market (104)
Layoffs (600)
Leadership (42)
Legal (8032)
Liver cancer (104)
Longevity (34)
Lung cancer (810)
Lymphoma (445)
Machine learning (61)
Management (59)
Manufacturing (1095)
MASH (208)
Medical device (14103)
Medtech (14236)
Mergers & acquisitions (20531)
Metabolic disorders (1601)
mRNA (240)
Multiple sclerosis (197)
NASH (20)
Neurodegenerative disease (459)
Neuropsychiatric disorders (115)
Neuroscience (3489)
Neurotech (1)
NextGen: Class of 2026 (6773)
Non-profit (4606)
Now hiring (79)
Obesity (756)
Opinion (314)
Ovarian cancer (233)
Pain (266)
Pancreatic cancer (320)
Parkinson's disease (392)
Partnered (34)
Patents (613)
Patient recruitment (712)
Peanut (63)
People (61137)
Pharmaceutical (79)
Pharmacy benefit managers (34)
Phase 1 (22944)
Phase 2 (32192)
Phase 3 (23753)
Pipeline (9190)
Policy (338)
Postmarket research (2607)
Preclinical (9847)
Press Release (67)
Prostate cancer (323)
Psychedelics (64)
Radiopharmaceuticals (356)
Rare diseases (1166)
Real estate (6083)
Recruiting (71)
Regulatory (26056)
Reports (56)
Research institute (2516)
Resumes & cover letters (355)
Rett syndrome (39)
RNA editing (27)
RSV (88)
Schizophrenia (187)
Series A (309)
Series B (227)
Service/supplier (11)
Sickle cell disease (121)
Special edition (29)
Spinal muscular atrophy (171)
Sponsored (49)
Startups (3836)
State (2)
Stomach cancer (19)
Supply chain (132)
Tariffs (88)
The Weekly (96)
Vaccines (1145)
Venture capital (120)
Weight loss (491)
Women's health (132)
Worklife (21)
Date
Today (38)
Last 7 days (622)
Last 30 days (3402)
Last 365 days (30979)
2026 (14037)
2025 (31061)
2024 (36285)
2023 (41011)
2022 (52276)
2021 (56759)
2020 (54917)
2019 (47413)
2018 (35693)
2017 (33021)
2016 (32345)
2015 (38395)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (759)
Alabama (99)
Alaska (7)
Arizona (361)
Arkansas (16)
Asia (41252)
Australia (6874)
California (13780)
Canada (3858)
China (1438)
Colorado (588)
Connecticut (608)
Delaware (418)
Europe (90800)
Florida (2036)
Georgia (440)
Hawaii (3)
Idaho (63)
Illinois (1103)
India (93)
Indiana (617)
Iowa (25)
Japan (563)
Kansas (135)
Kentucky (52)
Louisiana (45)
Maine (76)
Maryland (1640)
Massachusetts (9953)
Michigan (374)
Minnesota (745)
Mississippi (6)
Missouri (147)
Montana (35)
Nebraska (29)
Nevada (145)
New Hampshire (89)
New Jersey (3619)
New Mexico (32)
New York (3580)
North Carolina (1804)
North Dakota (10)
Northern California (6918)
Ohio (409)
Oklahoma (23)
Oregon (44)
Pennsylvania (2742)
Puerto Rico (29)
Rhode Island (51)
South America (1126)
South Carolina (86)
South Dakota (2)
Southern California (5414)
Tennessee (216)
Texas (2185)
United States (48688)
Utah (408)
Vermont (1)
Virginia (332)
Washington D.C. (82)
Washington State (1126)
West Virginia (4)
Wisconsin (135)
Wyoming (2)
748,777 Results for "mabwell therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mabwell Announces NMPA Approval of Supplemental Application for Additional Indications of MAIWEIJIAN (Denosumab Injection)
May 21, 2026
·
5 min read
Press Releases
Mabwell Establishes a Licensing and Commercialization Agreement for Denosumab Biosimilars in Malaysian Market
April 16, 2026
·
4 min read
Press Releases
Mabwell Announces Acceptance of Supplemental Biologics License Application by NMPA for MAIWEIJIAN (Denosumab)
April 16, 2026
·
5 min read
Press Releases
World’s First | Mabwell’s 9MW5211 Receives FDA Clearance for Clinical Trial Application
May 10, 2026
·
5 min read
Press Releases
Mabwell Announces Latest Clinical Data on 9MW2821 to Be Presented at 2026 ASCO Annual Meeting as Oral and Poster Presentations
May 22, 2026
·
5 min read
Press Releases
Mabwell Passes On-site GMP Inspection by Regulatory Authority of PIC/S Member Country (Jordan) for the First Time
April 21, 2026
·
4 min read
Press Releases
2026 ESMO GC | Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations
April 30, 2026
·
4 min read
Press Releases
Mabwell Initiates Phase III Clinical Study of its Nectin-4-Targeting ADC 9MW2821 for the Treatment of Triple-Negative Breast Cancer
April 23, 2026
·
5 min read
Press Releases
Case Report of Mabwell’s Nectin-4 targeting ADC (9MW2821) in Cervical Cancer Published in The New England Journal of Medicine
April 22, 2026
·
5 min read
Press Releases
2026 ASCO | Mabwell to Present Latest Clinical Data on 9MW2821 Combined with Toripalimab for Urothelial Carcinoma in Oral and Poster Presentations
April 23, 2026
·
4 min read
1 of 74,878
Next
